Is It Too Late to Buy Teladoc Health Stock?

Motley Fool2021-08-13

Teladoc Health (NYSE:TDOC) stock has been experiencing a bloodbath for much of the year, losing over 50% of its value since February, when it soared as high as $308 per share. The company has even ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

ahlai
2021-08-14
ahlai
No, it is not late
HF133
2021-08-14
HF133
Like and comment
Sunshine88
2021-08-14
Sunshine88
Like please
EAvenue
2021-08-14
EAvenue
Like and comment
- Bliang:
  A
- Trading Guru:
  ok
- Sunny0809:
  Ok
- Kalpana:
  ok
- MO75:
  ok
jyip93
2021-08-14
jyip93
Like and comment
- Pplymm:
  Done. pls like back
FU5591
2021-08-14
FU5591
nice
- jyip93:
  Like and comment

Leave a comment

246

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2159218651?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-13 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2159218651","market":"us","top_or_hot":-1,"title":"Is It Too Late to Buy Teladoc Health Stock?","media":"Motley Fool","content":"<div>\n<p>Teladoc Health (NYSE:TDOC) stock has been experiencing a bloodbath for much of the year, losing over 50% of its value since February, when it soared as high as $308 per share. The company has even ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/is-it-too-late-to-buy-teladoc-health-stock/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Too Late to Buy Teladoc Health Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Too Late to Buy Teladoc Health Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 23:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/is-it-too-late-to-buy-teladoc-health-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Teladoc Health (NYSE:TDOC) stock has been experiencing a bloodbath for much of the year, losing over 50% of its value since February, when it soared as high as $308 per share. The company has even ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/is-it-too-late-to-buy-teladoc-health-stock/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2021/08/13/is-it-too-late-to-buy-teladoc-health-stock/","article_id":"2159218651","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2159218651","pubTimestamp":1628867340,"columns":[],"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Many investors are skeptical about the future growth potential of the king of telehealth.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"现在购买Teladoc健康股票是否太晚？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":0.9},"content_text":"Teladoc Health (NYSE:TDOC) stock has been experiencing a bloodbath for much of the year, losing over 50% of its value since February, when it soared as high as $308 per share. The company has even attracted a dedicated community of short-sellers despite releasing spectacular growth results quarter after quarter. As a result, about 12.5% of the float is sold short. \nSkeptics see a grim future for the company as the pandemic wraps up and patients return to in-clinic visits. Should you be concerned about all the fear, uncertainty, and doubt surrounding Teladoc? \nA big nothingburger \nAt first glance, the bears seem to have a point: Telemedicine utilization is down 37% from pandemic highs. However, it is still 38 times higher than before COVID-19, and the numbers have stabilized. \nDuring the second quarter of 2021, Teladoc's total members remained roughly unchanged year over year at 52 million. Nevertheless, the company grew its revenue by 109% over the prior year's quarter to $503 million. This was largely due to an increase in platform utilization rates, which soared from 16% to 21.5%. It costs $12.95 per month to enroll in Teladoc's health program, and not all members seek consultations during the year.   \nIts subsidiary Livongo, which runs a digital health app that improves disease management for people with diabetes, performed remarkably. It added more than 200,000 members in the same period for a total of 715,000. Patient satisfaction remains high across both Teladoc and Livongo. The two apps are both rated 4.8 out of 5 stars by close to 340,000 reviewers on the Apple App Store. \nRecent surveys have shown that patients who utilize telehealth tend to have acute, low-intensity conditions that often resolve on their own, or are seeking treatment for chronic conditions. All this falls right into Teladoc's expertise. In addition to primary care, Teladoc offers a telepsychiatry platform, treating various conditions including anxiety, depression, and relationship conflicts. Seventy-six percent of patients report feeling better after their consultation, according to the company. \nMoving forward, its enterprise healthcare solutions will become one of two major catalysts for growth. More than 40% of Fortune 500 companies use Teladoc for their employees as part of health insurance packages.  The service has an ample value proposition, as online consultations are far cheaper than in-person ones overall. \nThe other area in which Teladoc could expand is telepharmacy. The company currently does not dispense drugs on its platform; it's focused on achieving growth in consultations and chronic disease management. But both of those services would synergize very well with the idea of becoming a telepharmacy, as that setup would allow in-house physicians to prescribe medications through a national fulfillment center, instead of requiring individual pharmacies to get involved after visits. \nThe key metric Teladoc nailed \nIn my opinion, it's not the company's increase in total visits, utilization rate, or revenue investors should be excited about. It's profitability. During the quarter, Teladoc generated $39.56 million in free cash flow -- its highest in history. Many old-school investors shunned Teladoc for its lack of profitability over the years, questioning how it could keep ramping up its physicians' pay to grow users and break even doing so. But happily, a sharp increase in utilization solved that problem.  This should settle the question for the time being. \nAll things considered, I expect Teladoc to sustain its growth through integration and expansion into just about every medical field suitable for telehealth. It is a solid healthcare stock to buy on the dip even at 11.5 times forward revenue. That's higher than the sector average, but the company has earned it, boasting a higher revenue growth rate than competitors including Amwell and Ontrak.","kind":"highlight","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":897356376,"gmtCreate":1628894436695,"gmtModify":1676529885049,"author":{"id":"3564626043064310","authorId":"3564626043064310","name":"ahlai","avatar":"https://static.tigerbbs.com/a9793982b5a1286b7c7b89debc6c9a93","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3564626043064310","authorIdStr":"3564626043064310"},"htmlText":"No, it is not late","listText":"No, it is not late","text":"No, it is not late","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897356376","repostId":2159218651,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":897350463,"gmtCreate":1628893783452,"gmtModify":1676529884936,"author":{"id":"3583621807888930","authorId":"3583621807888930","name":"HF133","avatar":"https://static.tigerbbs.com/ce211305e06a021e08ecfcbc0e23bbb5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583621807888930","authorIdStr":"3583621807888930"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897350463","repostId":2159218651,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":897350940,"gmtCreate":1628893646580,"gmtModify":1676529884911,"author":{"id":"3586140387931872","authorId":"3586140387931872","name":"Sunshine88","avatar":"https://static.tigerbbs.com/d4c6c15baca9f47c383ec0a6ca31c710","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3586140387931872","authorIdStr":"3586140387931872"},"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897350940","repostId":2159218651,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":897381790,"gmtCreate":1628886807510,"gmtModify":1676529884301,"author":{"id":"3584939916187250","authorId":"3584939916187250","name":"EAvenue","avatar":"https://static.tigerbbs.com/e3beb412a0aa565cfaac4f68f1721fd6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584939916187250","authorIdStr":"3584939916187250"},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/897381790","repostId":2159218651,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5521371,"gmtCreate":1628893222700,"gmtModify":1663232345345,"authorId":3573606104770883,"author":{"id":3573606104770883,"idStr":"3573606104770883","authorId":3573606104770883,"name":"Bliang","avatar":"https://static.tigerbbs.com/0d7cd18997f43a1b7035c0207a1c5872","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897381790,"type":1,"supId":0,"prevId":0,"content":"A","text":"A","html":"A"},{"id":5521328,"gmtCreate":1628892424318,"gmtModify":1663232344728,"authorId":3581082207694869,"author":{"id":3581082207694869,"idStr":"3581082207694869","authorId":3581082207694869,"name":"Trading Guru","avatar":"https://community-static.tradeup.com/news/765299bc38d48154b1dbbe7c431c8f70","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897381790,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5521279,"gmtCreate":1628891369496,"gmtModify":1663232344443,"authorId":3581539047362830,"author":{"id":3581539047362830,"idStr":"3581539047362830","authorId":3581539047362830,"name":"Sunny0809","avatar":"https://static.tigerbbs.com/3ffb7aab0292fd1f17dfb9f99bc5eb03","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897381790,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":5521293,"gmtCreate":1628891624331,"gmtModify":1663232344232,"authorId":3583487187442003,"author":{"id":3583487187442003,"idStr":"3583487187442003","authorId":3583487187442003,"name":"Kalpana","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897381790,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":5521386,"gmtCreate":1628893468485,"gmtModify":1663232343842,"authorId":3585255751373364,"author":{"id":3585255751373364,"idStr":"3585255751373364","authorId":3585255751373364,"name":"MO75","avatar":"https://static.tigerbbs.com/d033068949889afd8c31c73da66c8e75","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897381790,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":897383840,"gmtCreate":1628885309980,"gmtModify":1676529884268,"author":{"id":"3568615780432279","authorId":"3568615780432279","name":"jyip93","avatar":"https://static.tigerbbs.com/40bc8cd94658e02bab26b5fb8d25b2da","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3568615780432279","authorIdStr":"3568615780432279"},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/897383840","repostId":2159218651,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5521136,"gmtCreate":1628888784756,"gmtModify":1663232343454,"authorId":3582681835792049,"author":{"id":3582681835792049,"idStr":"3582681835792049","authorId":3582681835792049,"name":"Pplymm","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897383840,"type":1,"supId":0,"prevId":0,"content":"Done. pls like back","text":"Done. pls like back","html":"Done. pls like back"}],"langContent":"EN"},{"id":897380042,"gmtCreate":1628883899486,"gmtModify":1676529884204,"author":{"id":"3572502301692301","authorId":"3572502301692301","name":"FU5591","avatar":"https://static.tigerbbs.com/a0762ea32f762ec6978abe3695419890","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572502301692301","authorIdStr":"3572502301692301"},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/897380042","repostId":2159218651,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5521081,"gmtCreate":1628885326182,"gmtModify":1635152215862,"authorId":3568615780432279,"author":{"id":3568615780432279,"idStr":"3568615780432279","authorId":3568615780432279,"name":"jyip93","avatar":"https://static.tigerbbs.com/40bc8cd94658e02bab26b5fb8d25b2da","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":897380042,"type":1,"supId":0,"prevId":0,"content":"Like and comment ","text":"Like and comment ","html":"Like and comment "}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":246,"commentSize":16,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2159218651"}